1. McCracken GH Jr. Group B streptococci: the new challenge in neonatal infections. J Pediatr. 1973. 82:703–706.
2. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, Lefkowitz L, Danila R, Stefonek K, Barrett N, Morse D, Pinner R. Active Bacterial Core Surveillance Team of the Emerging Infections Program Network. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis. 2001. 7:92–99.
3. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, Wenger JD. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993. 269:221–226.
4. Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J. Massachusetts Department of Public Health Epidemiologists. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J. 2005. 24:17–23.
5. Kim JS, Jang YT, Kim JD, Park TH, Park JM, Kilgore PE, Kennedy WA, Park E, Nyambat B, Kim DR, Hwang PH, Kim SJ, Eun SH, Lee HS, Cho JH, Kim YS, Chang SJ, Huang HF, Clemens JD, Ward JI. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children. Vaccine. 2004. 22:3952–3962.
6. Shin S, Shin YJ, Ki M. Cost-benefit analysis of Haemophilus influenzae type B immunization in Korea. J Korean Med Sci. 2008. 23:176–184.
7. Choi E. Direct and indirect effects of pneumococcal protein conjugate vaccine. J Korean Med Assoc. 2008. 51:119–126.
9. Saarinen M, Takala AK, Koskenniemi E, Kela E, Rönnberg PR, Pekkanen E, Kiiski P, Eskola J. Finnish Pediatric Invasive Infection Study Group. Spectrum of 2,836 cases of invasive bacterial or fungal infections in children: results of prospective nationwide five-year surveillance in Finland. Clin Infect Dis. 1995. 21:1134–1144.
10. Nam SG, Lee HJ. Etiology of invasive bacterial infections in apparently healthy children. Korean J Infect Dis. 1998. 30:227–234.
11. Lee JH, Song EK, Lee JA, Kim NH, Kim DH, Park KW, Choi EH, Lee HJ. Clinical entities and etiology of invasive bacterial infections in apparently healthy children. Korean J Pediatr. 2005. 48:1193–1200.
12. Stoll BJ. Kligman RM, Behrman RE, Jenson HB, Stanton BF, editors. Infections of the neonatal infant. Nelson textbook of pediatrics. 2007. 18th ed. Philadelphia: Elsevier Saunders;794–811.
13. Kim KA, Shin SM, Choi JH. A nationwide survey on the causative organisms of neonatal sepsis in Korea. J Korean Pediatr Soc. 2002. 45:55–63.
14. Moon JH, Oh SH, Kim HW, Moon SJ, Choi TY. Neonatal sepsis and antimicrobial susceptibilities in the neonatal intensive care unit and nursery. Korean J Pediatr Infect Dis. 2002. 9:163–174.
15. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis. 2009. 48:922–930.
16. Lee JH, Park JJ, Sung IK, Lee BC. Clinical observation in 40 cases with neonatal sepsis. J Korean Pediatr Soc. 1990. 33:1489–1494.
17. Suryati BA, Watson M. Staphylococcus aureus bacteraemia in children: a 5-year retrospective review. J Paediatr Child Health. 2002. 38:290–294.
18. Sattler CA, Correa AG. Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, editors. Coagulase-positive staphylococcal infections (Staphylococcus aureus). Textbook of pediatric infectious diseases. 2004. 5th ed. Philadelphia: Elsevier Saunders;1099–1129.
19. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998. 339:520–532.
20. Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations-United States, 2003-2005. MMWR Morb Mortal Wkly Rep. 2007. 56:701–705.
21. Jang GC, Shin KM, Yong DE, Lee KW, Kim DS. Changing patterns of antibiotic-resistant rates and clinical features in pneumococcal infections. Korean J Pediatr Infect Dis. 2003. 10:81–86.
22. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 1999. Centers for Disease Control and Prevention. accessed on 18 Aug 2010. Available at
http://www.cdc.gov/abcs/survreports/spneu99.pdf.
23. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2005. Centers for Disease Control and Prevention. accessed on 18 Aug 2010. Available at
http://www.cdc.gov/abcs/survreports/spneu05.pdf.
24. Lee HJ. Epidemiology of systemic Haemophilus influenzae disease in Korean children. Pediatr Infect Dis J. 1998. 17:9 Suppl. S185–S189.
25. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000. 13:302–317.
26. Yagupsky P, Maimon N, Dagan R. Increasing incidence of nontyphi Salmonella bacteremia among children living in southern Israel. Int J Infect Dis. 2002. 6:94–97.
27. Ispahani P, Slack RC. Enteric fever and other extraintestinal salmonellosis in University Hospital, Nottingham, UK, between 1980 and 1997. Eur J Clin Microbiol Infect Dis. 2000. 19:679–687.
28. Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S, Smith K, Angulo FJ. Emerging Infections Program FoodNet Working Group. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis. 2004. 38:Suppl 3. S149–S156.
29. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, Wald ER, Givner LB, Kim KS, Yogev R, Kaplan SL. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998. 102:1087–1097.
30. Alpern ER, Alessandrini EA, Bell LM, Shaw KN, McGowan KL. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics. 2000. 106:505–511.